|
1
|
El-Serag HB: Epidemiology of viral
hepatitis and hepatocellular carcinoma. Gastroenterology.
142:1264–1273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lencioni: Loco-regional treatment of
hepatocellular carcinoma. Hepatology. 52:762–773. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nishikawa H and Osaki Y: Non-B, non-C
hepatocellular carcinoma (Review). Int J Oncol. 43:1333–1342.
2013.PubMed/NCBI
|
|
4
|
Llovet JM: Update treatment approach to
hepatocellular carcinoma. J Gastoenterol. 40:225–235. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Llovet JM, Ricci S, Mazzaferro V, Hilgard
P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A,
Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR,
Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici
M, Voliotis D and Bruix J: SHARP Investigators Study Group:
Sorafenib in advanced hepatocellular carcinoma. N Engl J Med.
359:378–390. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wo JY, Dawson LA, Zhu AX and Hong TS: An
emerging role for radiation therapy in the treatment of
hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Surg
Oncol Clin North Am. 23:353–368. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kawaguchi T, Izumi N, Charlton MR and Sata
M: Branched-chain amino acids as pharmacological nutrients in
chronic liver disease. Hepatology. 54:1063–1070. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
No authors listed. Nutritional status in
cirrhosis. Italian Multicentre Cooperative Project on Nutrition in
Liver Cirrhosis. J Hepatol. 21:317–335. 1994.PubMed/NCBI
|
|
10
|
Kuroda H, Ushio A, Miyamoto Y, Sawara K,
Oikawa K, Kasai K, Endo R, Takikawa Y, Kato A and Suzuki K: Effects
of branched-chain amino acid-enriched nutrient for patients with
hepatocellular carcinoma following radiofrequency ablation: a
one-year prospective trial. J Gastroenterol Hepatol. 25:1550–1555.
2010.
|
|
11
|
Kasugai H, Osaki Y, Oka H, Kudo M and Seki
T: Osaka Liver Cancer Study Group: Severe complications of
radiofrequency ablation therapy for hepatocellular carcinoma: an
analysis of 3,891 ablations in 2,614 patients. Oncology. 72(Suppl
1): 72–75. 2007. View Article : Google Scholar
|
|
12
|
Lautz HU, Selberg O, Körber J, Bürger M
and Müller MJ: Protein-calorie malnutrition in liver cirrhosis.
Clin Investig. 70:478–486. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kato M, Miwa Y, Tajika M, Hiraoka T, Muto
Y and Moriwaki H: Preferential use of branched-chain amino acids as
an energy substrate in patients with liver cirrhosis. Intern Med.
37:429–434. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kajiwara K, Okuno M, Kobayashi T, Honma N,
Maki T, Kato M, Ohnishi H, Muto Y and Moriwaki H: Oral
supplementation with branched chain amino acids improves survival
rate of rats with carbon tetrachloride-induced liver cirrhosis. Dig
Dis Sci. 43:1572–1579. 1998. View Article : Google Scholar
|
|
15
|
Yosida T, Muto Y, Moriwaki H and Yamato M:
Effect of long-term oral supplementation with branched chain amino
acid granules on the prognosis of liver cirrhosis. J Gastroenterol.
24:692–698. 1989.PubMed/NCBI
|
|
16
|
Marchesini G, Dioguardi FS, Bianchi GP,
Zoli M, Bellati G, Roffi L, Martines D and Abbiati R: Long-term
oral branched-chain amino acid treatment in chronic hepatic
encephalopathy: a randomized double blind casein-controlled trial.
J Hepatol. 11:92–101. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Marchesini G, Bianchi G, Merli M, Amodio
P, Panella C, Loguercio C, Rossi Fanelli F and Abbiati R: Italian
BCAA Study Group: Nutritional supplementation with branched chain
amino acids in advanced cirrhosis: a double-blind, randomized
trial. Gastroenterology. 124:1792–1801. 2003. View Article : Google Scholar
|
|
18
|
Keshavarzian A, Meek J, Sutton C, Emery
VM, Hughes EA and Hodgson HJ: Dietary protein supplementation from
vegetable sources in the management of chronic portal systemic
encephalopathy. Am J Gastroenterol. 79:945–949. 1984.
|
|
19
|
Kumada H, Okanoue T, Onji M, Moriwaki H,
Izumi N, Tanaka E, Chayama K, Sakisaka S, Takehara T, Oketani M,
Suzuki F, Toyota J, Nomura H, Yoshioka K, Seike M, Yotsuyanagi H
and Ueno Y: Study Group for the Standardization of Treatment of
Viral Hepatitis Including Cirrhosis, Ministry of Health, Labour and
Welfare of Japan: Guidelines for the treatment of chronic hepatitis
and cirrhosis due to hepatitis C virus infection for the fiscal
year 2008 in Japan. Hepatol Res. 40:8–13. 2010.
|
|
20
|
Saito Y, Saito H, Nakamura M, Wakabayashi
K, Takagi T, Ebinuma H and Ishii H: Effect of the molar ratio of
branched-chain to aromatic amino acids on growth and albumin mRNA
expression of human liver cancer cell lines in a serum-free medium.
Nutr Cancer. 39:126–131. 2001. View Article : Google Scholar
|
|
21
|
Muto Y, Sato S, Watanabe A, Moriwaki H,
Suzuki K, Kato A, Kato M, Nakamura T, Higuchi K, Nishiguchi S,
Kumada H and Ohashi Y: Long-Term Survival Study (LOTUS) Group:
Overweight and obesity increase the risk for liver cancer in
patients with liver cirrhosis and long-term oral supplementation
with branched-chain amino acid granules inhibits liver
carcinogenesis in heavier patients with liver cirrhosis. Hepatol
Res. 35:204–214. 2006.
|
|
22
|
Yoshiji H, Noguchi R, Kitade M, Kaji K,
Ikenaka Y, Namisaki T, Yoshii J, Yanase K, Yamazaki M, Tsujimoto T,
Akahane T, Kawaratani H, Uemura M and Fukui H: Branched-chain amino
acids suppress insulin-resistance-based hepatocarcinogenesis in
obese diabetic rats. J Gastroenterol. 44:483–491. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sugiyama K, Yu L and Nagasue N: Direct
effect of branched-chain amino acids on the growth and metabolism
of cultured human hepatocellular carcinoma cells. Nutr Cancer.
31:62–68. 1998. View Article : Google Scholar
|
|
24
|
Nishikawa H, Osaki Y, Iguchi E, Koshikawa
Y, Ako S, Inuzuka T, Takeda H, Nakajima J, Matsuda F, Sakamoto A,
Henmi S, Hatamaru K, Ishikawa T, Saito S, Nasu A, Kita R and Kimura
T: The effect of long-term supplementation with branched-chain
amino acid granules in patients with hepatitis C virus-related
hepatocellular carcinoma after radiofrequency thermal ablation. J
Clin Gastroenterol. 47:359–366. 2013. View Article : Google Scholar
|
|
25
|
Nishiguchi S and Habu D: Effect of oral
supplementation with branched-chain amino acid granules in the
early stage of cirrhosis. Hepatol Res. 30S:36–41. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Habu D, Nishiguchi S, Nakatani S, Kawamura
E, Lee C, Enomoto M, Tamori A, Takeda T, Tanaka T and Shiomi S:
Effect of oral supplementation with branched-chain amino acid
granules on serum albumin level in the early stage of cirrhosis: a
randomized pilot trial. Hepatol Res. 25:312–318. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nishikawa H, Osaki Y, Inuzuka T, Takeda H,
Nakajima J, Matsuda F, Henmi S, Sakamoto A, Ishikawa T, Saito S,
Kita R and Kimura T: Branched-chain amino acid treatment before
transcatheter arterial chemoembolization for hepatocellular
carcinoma. World J Gastroenterol. 18:1379–1384. 2012. View Article : Google Scholar
|
|
28
|
Bruix J and Sherman M: Practice Guidelines
Committee, American Association for the Study of Liver Diseases:
Management of hepatocellular carcinoma. Hepatology. 42:1208–1236.
2005. View Article : Google Scholar
|
|
29
|
Yamasaki T, Kurokawa F, Shirahashi H,
Kusano N, Hironaka K and Okita K: Percutaneous radiofrequency
ablation therapy with combined angiography and computed tomography
assistance for patients with hepatocellular carcinoma. Cancer.
91:1342–1348. 2001. View Article : Google Scholar
|
|
30
|
Park JW, Amarapurkar D, Chao Y, Chen PJ,
Geschwind JF, Goh KL, Han KH, Kudo M, Lee HC, Lee RC, Lesmana LA,
Lim HY, Paik SW, Poon RT, Tan CK, Tanwandee T, Teng G and Cheng AL:
Consensus recommendations and review by an International Expert
Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC). Liver
Int. 33:327–337. 2013. View Article : Google Scholar
|
|
31
|
Kudo M, Izumi N, Kokudo N, Matsui O,
Sakamoto M, Nakashima O, Kojiro M and Makuuchi M: HCC Expert Panel
of Japan Society of Hepatology. Management of hepatocellular
carcinoma in Japan: Consensus-Based Clinical Practice Guidelines
proposed by the Japan Society of Hepatology (JSH) 2010 updated
version. Dig Dis. 29:339–364. 2011. View Article : Google Scholar
|
|
32
|
Austin PC: A comparison of 12 algorithms
for matching on the propensity score. Stat Med. 33:1057–1069. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
D’Agostino RB Jr: Propensity score methods
for bias reduction in the comparison of a treatment to a
non-randomized control group. Stat Med. 17:2265–2281. 1998.
|
|
34
|
Kawaguchi T and Sata M: Importance of
hepatitis C virus-associated insulin resistance: therapeutic
strategies for insulin sensitization. World J Gastroenterol.
16:1943–1952. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kawaguchi T, Yamagishi S and Sata M:
Branched-chain amino acids and pigment epithelium-derived factor:
novel therapeutic agents for hepatis c virus-associated insulin
resistance. Curr Med Chem. 16:4843–4857. 2009. View Article : Google Scholar
|
|
36
|
Choudry HA, Pan M, Karinch AM and Souba
WW: Branched-chain amino acid-enriched nutritional support in
surgical and cancer patients. J Nutr. 136(Suppl 1): S314–S318.
2006.PubMed/NCBI
|
|
37
|
Ichikawa K, Okabayashi T, Maeda H,
Namikawa T, Iiyama T, Sugimoto T, Kobayashi M, Mimura T and
Hanazaki K: Oral supplementation of branched-chain amino acids
reduces early recurrence after hepatic resection in patients with
hepatocellular carcinoma: a prospective study. Surg Today.
43:720–726. 2013. View Article : Google Scholar
|
|
38
|
Takaguchi K, Moriwaki H, Doyama H, Iida M,
Yagura M, Shimada N, Kang M, Yamada H and Kumada H: Effects of
branched-chain amino acid granules on serum albumin level and
prognosis are dependent on treatment adherence in patients with
liver cirrhosis. Hepatol Res. 43:459–466. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mazzaferro V, Romito R, Schiavo M, Mariani
L, Camerini T, Bhoori S, Capussotti L, Calise F, Pellicci R, Belli
G, Tagger A, Colombo M, Bonino F, Majno P and Llovet JM: HCC
Italian Task Force: Prevention of hepatocellular carcinoma
recurrence with alpha-interferon after liver resection in HCV
cirrhosis. Hepatology. 44:1543–1554. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nishikawa H, Nishijima N, Arimoto A,
Inuzuka T, Kita R, Kimura T and Osaki Y: Effect of nucleoside
analog use in patients with hepatitis B virus-related
hepatocellular carcinoma. Hepatol Res. May 24–2013.(Epub ahead of
print). View Article : Google Scholar
|
